Article Information
History
- November 26, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Gabriela D. A. Guardia1,*,
- Carlos H dos Anjos1,*,
- Aline Rangel-Pozzo2,
- Filipe F. dos Santos1,3,
- Alexander Birbrair4,
- Paula F. Asprino1,
- Anamaria A. Camargo1 and
- Pedro A F Galante1,#
- 1Centro de Oncologia Molecular, Hospital Sirio Libanes, Sao Paulo, Brazil
- 2Depart. of Physiology and Pathophysiology, CancerCare Manitoba Research Institute, University of Manitoba, Winnipeg, Canada
- 3Depart. de Bioquímica, Universidade de Sao Paulo, Brazil
- 4Depart. of Dermatology, University of Wisconsin-Madison, Madison, USA
- ↵#corresponding author: pgalante{at}mochsl.org.br
Posted November 26, 2024.
Beyond HER2 expression in breast cancer: Investigating alternative splicing profiles as a mechanism of resistance to anti-HER2 therapies
